Travere Therapeutics Inc
(TVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,809 | -25,260 | 808 | -146,427 | -116,168 |
| Depreciation Amortization | 26,265 | 16,991 | 8,345 | 55,023 | 21,736 |
| Accounts receivable | 3,195 | 3,979 | -61 | -5,184 | -3,989 |
| Accounts payable and accrued liabilities | -10,213 | -16,407 | -16,577 | 9,255 | 4,962 |
| Other Working Capital | -24,936 | -34,721 | -36,237 | 2,624 | -2,549 |
| Other Operating Activity | 24,625 | 19,810 | 14,567 | 26,495 | 42,286 |
| Operating Cash Flow | $-28,873 | $-35,608 | $-29,155 | $-58,214 | $-53,722 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 80,149 | 116,403 | 44,165 | 35,428 | 29,868 |
| PPE Investments | -2,926 | -518 | -208 | -195 | -286 |
| Purchase Sale Intangibles | -13,039 | -8,532 | -4,406 | -15,370 | -11,299 |
| Other Investing Activity | -13,039 | -8,532 | -4,406 | -15,370 | -11,299 |
| Investing Cash Flow | $64,184 | $107,353 | $39,551 | $19,863 | $18,283 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 110,037 | 109,075 | 60 | 1,618 | 944 |
| Other Financing Activity | -7,363 | -6,053 | -5,833 | -3,695 | -3,116 |
| Financing Cash Flow | $102,674 | $103,022 | $-5,773 | $-2,077 | $-2,172 |
| Exchange Rate Effect | 60 | -33 | -40 | -9 | -74 |
| Beginning Cash Position | 62,436 | 62,436 | 62,436 | 102,873 | 102,873 |
| End Cash Position | 200,481 | 237,170 | 67,019 | 62,436 | 65,188 |
| Net Cash Flow | $138,045 | $174,734 | $4,583 | $-40,437 | $-37,685 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,873 | -35,608 | -29,155 | -58,214 | -53,722 |
| Capital Expenditure | -2,926 | -518 | -208 | -195 | -286 |
| Free Cash Flow | -31,799 | -36,126 | -29,363 | -58,409 | -54,008 |